195 related articles for article (PubMed ID: 30280243)
1. How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
Erman A; Kapun G; Novak S; Pavlin M; Dražić G; Drobne D; Veranič P
Histochem Cell Biol; 2019 Mar; 151(3):263-273. PubMed ID: 30280243
[TBL] [Abstract][Full Text] [Related]
2. Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model.
Luo Y; Chen X; O'donnell MA
J Urol; 2004 Dec; 172(6 Pt 1):2414-20. PubMed ID: 15538283
[TBL] [Abstract][Full Text] [Related]
3. How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients.
Erman A; Kamenšek U; Dragin Jerman U; Pavlin M; Čemažar M; Veranič P; Romih R
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199232
[TBL] [Abstract][Full Text] [Related]
4. Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by Light and Electron Microscopy.
Erman A; Kamenšek U; Peskar D; Veranič P
Methods Mol Biol; 2024; 2773():33-49. PubMed ID: 38236534
[TBL] [Abstract][Full Text] [Related]
5. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model.
Chade DC; Andrade PM; Borra RC; Leite KR; Andrade E; Villanova FE; Srougi M
Int Braz J Urol; 2008; 34(2):220-6; discussion 226-9. PubMed ID: 18462521
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer.
Huang CP; Chen CC; Shyr CR
Cytotherapy; 2017 Oct; 19(10):1233-1245. PubMed ID: 28818454
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer.
Brocks CP; Büttner H; Böhle A
J Urol; 2005 Sep; 174(3):1115-8. PubMed ID: 16094076
[TBL] [Abstract][Full Text] [Related]
8. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
Xiao Z; Mak A; Koch K; Moore RB
BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
[TBL] [Abstract][Full Text] [Related]
9. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer].
Liang ZK; Zhang L; Hu ZM; Chen Z; Huang X; Shi XH; Tan WL; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and application of an orthotopic murine bladder cancer model].
Yang SM; Wen DG; Hou JQ; He J; Cen JN; Chen JH
Ai Zheng; 2007 Apr; 26(4):341-5. PubMed ID: 17430648
[TBL] [Abstract][Full Text] [Related]
11. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer.
Lodillinsky C; Rodriguez V; Vauthay L; Sandes E; Casabé A; Eiján AM
J Urol; 2009 Aug; 182(2):749-55. PubMed ID: 19539312
[TBL] [Abstract][Full Text] [Related]
12. A new in vivo model for studying invasion and metastasis of rat and human bladder carcinomas.
Kameyama S; Kawamata H; Kawai K; Oyasu R
Carcinogenesis; 1993 Aug; 14(8):1531-5. PubMed ID: 8353837
[TBL] [Abstract][Full Text] [Related]
13. ras induced lesions in a heterotopic mouse bladder.
Wagner HE; Joyce AD; Beatrice K; Summerhayes IC
Oncogene; 1990 Apr; 5(4):557-63. PubMed ID: 2183157
[TBL] [Abstract][Full Text] [Related]
14. Optimizing syngeneic orthotopic murine bladder cancer (MB49).
Günther JH; Jurczok A; Wulf T; Brandau S; Deinert I; Jocham D; Böhle A
Cancer Res; 1999 Jun; 59(12):2834-7. PubMed ID: 10383142
[TBL] [Abstract][Full Text] [Related]
15. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
[TBL] [Abstract][Full Text] [Related]
16. Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments.
Horiguchi Y; Kikuchi E; Ozu C; Nishiyama T; Oyama M; Horinaga M; Yoshioka K; Tachibana M
Hum Cell; 2008 Aug; 21(3):57-63. PubMed ID: 18667021
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model.
Codolo G; Munari F; Fassan M; de Bernard M
J Vis Exp; 2015 May; (99):e52743. PubMed ID: 26068073
[TBL] [Abstract][Full Text] [Related]
18. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
19. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
Nativ O; Dalal E; Hidas G; Aronson M
Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016
[TBL] [Abstract][Full Text] [Related]
20. Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models.
Zupančič D; Kreft ME; Romih R
Protoplasma; 2014 Jan; 251(1):49-59. PubMed ID: 23828036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
